Skip to main content
. 2018 Nov 26;190(47):E1384–E1388. doi: 10.1503/cmaj.180897

Table 1:

Financing of prescription drugs with and without universal pharmacare in 2020*

Total expenditure Without pharmacare, $ billions With pharmacare, $ billions Change
Drugs on the national formulary
Paid through taxes 13.5 23.2 9.7
Paid directly and through private insurance premiums 14.3 0.5 −13.9
Subtotal: drugs on national formulary 27.9 23.7 −4.2
Drugs not on the national formulary
Paid through taxes 1.4 1.4 0.0
Paid directly and through private insurance premiums 3.2 3.2 0.0
Subtotal: drugs not on national formulary 4.6 4.6 0.0
Grand total 32.5 28.3 −4.2
*

Authors’ calculations based on estimates of the Parliamentary Budget Officer.12